Daily News & Analysis | Merck hepatitis C drugs shine in easier to treat patients Daily News & Analysis Friday to present results of how the Merck pills fared in more difficult to treat patients, such has those who failed to be helped by prior treatments and those with more advanced liver disease. In the arm of the Phase II study presented on Thursday ... |
